Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-29

Clinical Trial Update: A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating renal hemodynamic responses to aliskiren in patients with type 2 diabetes mellitus was completed, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2012-08-29